CAS 233275-76-8

MK 0343

CAS: 233275-76-8

Formula: C₁₉H₁₇F₂N₇O

Purity: 99%

Color and Shape: Solid

Molecular weight: 397.3814

Ref: IN-DA00BFC6

MK 0343

CAS: 233275-76-8

Purity: 95.0%

Molecular weight: 397.39

Ref: 10-F500537

MK 0343

CAS: 233275-76-8

MK 0343 is a drug that has been in clinical development for the treatment of anxiety and depression. It is a non-selective benzodiazepine that binds to the GABA receptor, leading to an increase in gamma-aminobutyric acid (GABA) levels. MK 0343 has been shown to be effective in treating anxiety and depression. This drug has a low risk of abuse potential because it does not have the same effects on the central nervous system as other benzodiazepines. MK 0343 has also been shown to be safe for use in humans, with no sedating effects at doses up to 100mg/day.
MK 0343 is currently undergoing clinical trials for the treatment of major depressive disorder, generalized anxiety disorder, posttraumatic stress disorder, and social anxiety disorder.

Formula: C₁₉H₁₇F₂N₇O

Purity: Min. 95%

Molecular weight: 397.38 g/mol

Ref: 3D-IJA27576

MK-0343

CAS: 233275-76-8

MK0343 is an orally bioavailable GABAA receptor subtype-selective partial agonist and is a non-sedating anxiolytic.

Formula: C₁₉H₁₇F₂N₇O

Purity: 98%

Color and Shape: Solid

Molecular weight: 397.38

Ref: TM-T16084